• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估在气液界面培养的人鼻RPMI 2650细胞作为鼻药物转运研究模型的情况。

Evaluation of human nasal RPMI 2650 cells grown at an air-liquid interface as a model for nasal drug transport studies.

作者信息

Bai Shuhua, Yang Tianzhi, Abbruscato Thomas J, Ahsan Fakhrul

机构信息

Department of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, 1300 Coulter Drive, Amarillo, TX 79106, USA.

出版信息

J Pharm Sci. 2008 Mar;97(3):1165-78. doi: 10.1002/jps.21031.

DOI:10.1002/jps.21031
PMID:17628494
Abstract

This study tests the hypothesis that human nasal RPMI 2650 cells grown at an air-liquid interface is a feasible model for drug transport studies via the nasal route. RPMI 2650 cells were cultured in Eagle's minimal essential medium (MEM) at both air-liquid and liquid-liquid interfaces. For each culture regimen, monolayer integrity was tested by measuring the transepithelial resistance (TEER) as well as the transport of paracellular and transcellular markers across the monolayer. The expression of tight junction proteins-differentiation markers-in cells of the different monolayers was studied by western blot analysis and confocal microscopy. The highest TEER values (192 +/- 3 Omega . cm2) were observed for RPMI 2650 cells seeded onto collagen-coated permeable polytetrafluoroethylene inserts and grown at an air-liquid interface for 10 days; a seeding density of 4 x 10(5)/cm2 generated and maintained a cell monolayer with suitable barrier properties at days 9-12. Microscopic examination showed that RPMI 2650 cells grown on filter inserts formed a fully confluent monolayer. The apparent permeability coefficients of the paracellular marker, [14C] mannitol, and the transcellular marker, [3H] propranolol, were 5.07 +/- 0.01 x 10(-6) cm/s and 16.1 +/- 0.1 x 10(-6) cm/s, respectively. Western blot analysis indicated the presence of four tight junction proteins: ZO-1, occludin, claudin-1 and E-cadherin; and the quantities of ZO-1, occludin, and E-cadherin were significantly higher in cells grown at an air-liquid interface than in cells grown at a liquid-liquid interface. Confocal microscopic studies showed ZO-1, F-actin, occludin and claudin-1 proteins at cell-cell contacts and revealed significant differences in the distributions and densities of ZO-1 protein in cells grown at the two types of interface. The data indicate that RPMI 2650 cells grown at an air-liquid interface form polarized monolayers with the cells interconnected by tight junction proteins. This human nasal cell line model could provide a useful tool for in vitro screening of nasal drug candidates.

摘要

本研究检验了以下假设

在气液界面培养的人鼻RPMI 2650细胞是通过鼻腔途径进行药物转运研究的可行模型。RPMI 2650细胞在气液界面和液液界面的伊格尔最低限度基本培养基(MEM)中培养。对于每种培养方案,通过测量跨上皮电阻(TEER)以及细胞旁和跨细胞标志物跨单层的转运来测试单层完整性。通过蛋白质印迹分析和共聚焦显微镜研究不同单层细胞中紧密连接蛋白(分化标志物)的表达。将RPMI 2650细胞接种到胶原包被的可渗透聚四氟乙烯插入物上并在气液界面培养10天,观察到最高的TEER值(192±3Ω.cm2);接种密度为4×10(5)/cm2在第9 - 12天产生并维持了具有合适屏障特性的细胞单层。显微镜检查显示,在滤膜插入物上生长的RPMI 2650细胞形成了完全汇合的单层。细胞旁标志物[14C]甘露醇和跨细胞标志物[3H]普萘洛尔的表观渗透系数分别为5.07±0.01×10(-6) cm/s和16.1±0.1×10(-6) cm/s。蛋白质印迹分析表明存在四种紧密连接蛋白:ZO - 1、闭合蛋白、Claudin - 1和E - 钙黏蛋白;在气液界面生长的细胞中,ZO - 1、闭合蛋白和E - 钙黏蛋白的量显著高于在液液界面生长的细胞。共聚焦显微镜研究显示,在细胞 - 细胞接触处有ZO - 1、F - 肌动蛋白、闭合蛋白和Claudin - 1蛋白,并揭示了在两种界面生长的细胞中ZO - 1蛋白分布和密度的显著差异。数据表明,在气液界面生长的RPMI 2650细胞形成了极化单层,细胞通过紧密连接蛋白相互连接。这种人鼻细胞系模型可为鼻腔候选药物的体外筛选提供有用工具。

相似文献

1
Evaluation of human nasal RPMI 2650 cells grown at an air-liquid interface as a model for nasal drug transport studies.评估在气液界面培养的人鼻RPMI 2650细胞作为鼻药物转运研究模型的情况。
J Pharm Sci. 2008 Mar;97(3):1165-78. doi: 10.1002/jps.21031.
2
Rhinovirus infection-induced alteration of tight junction and adherens junction components in human nasal epithelial cells.人鼻腔上皮细胞中鼻病毒感染诱导的紧密连接和黏着连接成分改变。
Laryngoscope. 2010 Feb;120(2):346-52. doi: 10.1002/lary.20764.
3
Serially passaged human nasal epithelial cell monolayer for in vitro drug transport studies.用于体外药物转运研究的连续传代人鼻上皮细胞单层。
Pharm Res. 2003 Oct;20(10):1690-6. doi: 10.1023/a:1026112107100.
4
The cell line NCl-H441 is a useful in vitro model for transport studies of human distal lung epithelial barrier.细胞系NCl-H441是用于人类远端肺上皮屏障转运研究的有用体外模型。
Mol Pharm. 2014 Mar 3;11(3):995-1006. doi: 10.1021/mp4006535. Epub 2014 Feb 20.
5
Establishment of a confluent monolayer model with human primary trophoblast cells: novel insights into placental glucose transport.用人原代滋养层细胞建立汇合单层模型:对胎盘葡萄糖转运的新见解。
Mol Hum Reprod. 2016 Jun;22(6):442-56. doi: 10.1093/molehr/gaw018. Epub 2016 Feb 29.
6
The characterization of the human nasal epithelial cell line RPMI 2650 under different culture conditions and their optimization for an appropriate in vitro nasal model.人鼻上皮细胞系RPMI 2650在不同培养条件下的特性及其对合适的体外鼻模型的优化。
Pharm Res. 2015 Feb;32(2):665-79. doi: 10.1007/s11095-014-1494-0. Epub 2014 Aug 22.
7
Application of RPMI 2650 as a cell model to evaluate solid formulations for intranasal delivery of drugs.应用RPMI 2650作为细胞模型来评估用于鼻腔给药的固体剂型。
Int J Pharm. 2016 Dec 30;515(1-2):1-10. doi: 10.1016/j.ijpharm.2016.09.086. Epub 2016 Oct 1.
8
Comparison of RPMI 2650 cell layers and excised sheep nasal epithelial tissues in terms of nasal drug delivery and immunocytochemistry properties.RPMI 2650 细胞层与离体绵羊鼻腔黏膜组织在鼻腔给药和免疫细胞化学特性方面的比较。
J Pharmacol Toxicol Methods. 2022 Jan-Feb;113:107131. doi: 10.1016/j.vascn.2021.107131. Epub 2021 Oct 24.
9
Evaluation of bEnd5 cell line as an in vitro model for the blood-brain barrier under normal and hypoxic/aglycemic conditions.评估bEnd5细胞系作为正常及缺氧/无糖条件下血脑屏障的体外模型。
J Pharm Sci. 2007 Dec;96(12):3196-213. doi: 10.1002/jps.21002.
10
Establishment of an in vitro brain barrier epithelial transport system for pharmacological and toxicological study.建立用于药理学和毒理学研究的体外脑屏障上皮转运系统。
Brain Res. 2005 Sep 28;1057(1-2):37-48. doi: 10.1016/j.brainres.2005.07.046.

引用本文的文献

1
Intranasal Administration of Extracellular Vesicles Derived from Adipose Mesenchymal Stem Cells Has Therapeutic Effect in Experimental Autoimmune Encephalomyelitis.经鼻给予脂肪间充质干细胞来源的细胞外囊泡对实验性自身免疫性脑脊髓炎具有治疗作用。
Cells. 2025 Jul 30;14(15):1172. doi: 10.3390/cells14151172.
2
Improving Ex Vivo Nasal Mucosa Experimental Design for Drug Permeability Assessments: Correcting Mucosal Thickness Interference and Reevaluating Fluorescein Sodium as an Integrity Marker for Chemically Induced Mucosal Injury.改进用于药物渗透性评估的离体鼻黏膜实验设计:校正黏膜厚度干扰并重新评估荧光素钠作为化学诱导黏膜损伤的完整性标志物
Pharmaceuticals (Basel). 2025 Jun 13;18(6):889. doi: 10.3390/ph18060889.
3
Intranasal Delivery of Metabolically Resilient Glutathione: Pharmacokinetic, Permeation, and Efficacy Studies.
代谢适应性谷胱甘肽的鼻腔给药:药代动力学、渗透及疗效研究
Mol Pharm. 2025 Jul 7;22(7):4145-4157. doi: 10.1021/acs.molpharmaceut.5c00382. Epub 2025 May 22.
4
Evaluation of Drug Permeation Enhancement by Using In Vitro and Ex Vivo Models.使用体外和离体模型评估药物渗透增强作用
Pharmaceuticals (Basel). 2025 Jan 31;18(2):195. doi: 10.3390/ph18020195.
5
Characterization of a primary cellular airway model for inhalative drug delivery in comparison with the established permanent cell lines CaLu3 and RPMI 2650.与已建立的永生化细胞系CaLu3和RPMI 2650相比,一种用于吸入药物递送的原代细胞气道模型的表征。
In Vitro Model. 2024 Nov 25;3(4-6):183-203. doi: 10.1007/s44164-024-00079-y. eCollection 2024 Dec.
6
A Modified Cell-Penetrating Peptide Enhances Insulin and Oxytocin Delivery across an RPMI 2650 Nasal Epithelial Cell Barrier In Vitro.一种改良的细胞穿透肽增强胰岛素和催产素在体外跨RPMI 2650鼻上皮细胞屏障的递送。
Pharmaceutics. 2024 Sep 28;16(10):1267. doi: 10.3390/pharmaceutics16101267.
7
A Cell-Based Nasal Model for Screening the Deposition, Biocompatibility, and Transport of Aerosolized PLGA Nanoparticles.一种用于筛选雾化聚乳酸-羟基乙酸共聚物纳米颗粒沉积、生物相容性和转运的基于细胞的鼻腔模型
Mol Pharm. 2024 Mar 4;21(3):1108-1124. doi: 10.1021/acs.molpharmaceut.3c00639. Epub 2024 Feb 9.
8
Solid Lipid Nanoparticles Containing Dopamine and Grape Seed Extract: Freeze-Drying with Cryoprotection as a Formulation Strategy to Achieve Nasal Powders.载有多巴胺和葡萄籽提取物的固体脂质纳米粒:作为实现鼻腔粉末的制剂策略的冷冻干燥与抗冻保护。
Molecules. 2023 Nov 22;28(23):7706. doi: 10.3390/molecules28237706.
9
Characterization of critical parameters using an air-liquid interface model with RPMI 2650 cells for permeability studies of small molecules.采用 RPMI 2650 细胞气液界面模型对小分子进行渗透研究,以确定关键参数的特征。
Drug Deliv Transl Res. 2024 Jun;14(6):1601-1615. doi: 10.1007/s13346-023-01474-w. Epub 2023 Nov 17.
10
The Path from Nasal Tissue to Nasal Mucosa on Chip: Part 2-Advanced Microfluidic Nasal In Vitro Model for Drug Absorption Testing.从鼻组织到芯片上鼻黏膜的路径:第2部分——用于药物吸收测试的先进微流控鼻体外模型。
Pharmaceutics. 2023 Oct 9;15(10):2439. doi: 10.3390/pharmaceutics15102439.